Wall Street Experts
ver. ZuMIgo(08/25)
Basilea Pharmaceutica AG
Rachunek Zysków i Strat
Przychody TTM (mln): 323
EBIT TTM (mln): 66
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
Rok finansowy |
2002 |
2003 |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
Przychód (mln) |
0 |
0 |
0 |
30 |
7 |
8 |
12 |
27 |
116 |
66 |
58 |
41 |
42 |
53 |
66 |
102 |
133 |
134 |
128 |
148 |
148 |
158 |
Przychód Δ r/r |
0.0% |
85.6% |
-24.4% |
10536.4% |
-76.4% |
9.9% |
51.6% |
124.1% |
330.7% |
-42.8% |
-11.8% |
-29.8% |
3.8% |
24.3% |
24.9% |
53.9% |
30.6% |
1.4% |
-5.0% |
16.1% |
-0.2% |
6.7% |
Marża brutto |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
97.7% |
93.9% |
100.0% |
96.4% |
92.5% |
-30.3% |
-27.9% |
-13.7% |
18.5% |
36.9% |
5.5% |
86.0% |
81.2% |
83.7% |
81.9% |
83.0% |
EBIT (mln) |
-63 |
-56 |
-76 |
-51 |
-88 |
-136 |
-153 |
-121 |
108 |
-57 |
-51 |
-33 |
-42 |
-61 |
-44 |
-14 |
-23 |
-17 |
-23 |
1 |
16 |
19 |
EBIT Δ r/r |
0.0% |
-11.0% |
35.5% |
-32.9% |
73.0% |
55.2% |
11.8% |
-20.5% |
-188.8% |
-153.2% |
-11.2% |
-34.5% |
25.7% |
47.0% |
-28.6% |
-67.8% |
63.8% |
-25.7% |
35.2% |
-105.0% |
1294.5% |
17.5% |
EBIT (%) |
-30742.9% |
-14736.2% |
-26409.9% |
-166.7% |
-1224.0% |
-1727.8% |
-1273.6% |
-451.8% |
93.2% |
-86.5% |
-87.2% |
-81.3% |
-98.4% |
-116.4% |
-66.5% |
-13.9% |
-17.5% |
-12.8% |
-18.2% |
0.8% |
11.1% |
12.2% |
Koszty finansowe (mln) |
-4 |
-0 |
-0 |
0 |
-3 |
-10 |
-9 |
-1 |
-0 |
-0 |
1 |
0 |
0 |
0 |
9 |
10 |
10 |
8 |
10 |
11 |
11 |
16 |
EBITDA (mln) |
-59 |
-51 |
-71 |
-46 |
-82 |
-124 |
-148 |
-116 |
112 |
-54 |
-47 |
-31 |
-40 |
-59 |
-42 |
-12 |
-21 |
-16 |
-21 |
4 |
19 |
23 |
EBITDA(%) |
-29093.1% |
-13483.1% |
-24829.5% |
-150.4% |
-1144.0% |
-1571.4% |
-1239.2% |
-433.3% |
96.7% |
-82.2% |
-80.9% |
-74.7% |
-93.0% |
-112.0% |
-63.2% |
-12.1% |
-16.1% |
-11.6% |
-16.4% |
2.4% |
13.2% |
14.4% |
Podatek (mln) |
-4 |
-0 |
-0 |
-1 |
-3 |
-10 |
-9 |
1 |
1 |
1 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
-0 |
0 |
Zysk Netto (mln) |
-59 |
-56 |
-75 |
-50 |
-85 |
-127 |
-144 |
-121 |
108 |
-58 |
-53 |
-33 |
-42 |
-62 |
-51 |
-19 |
-31 |
-22 |
-15 |
-7 |
12 |
10 |
Zysk netto Δ r/r |
0.0% |
-5.6% |
35.6% |
-34.3% |
71.7% |
48.9% |
13.2% |
-15.9% |
-189.1% |
-153.6% |
-8.0% |
-37.7% |
25.8% |
48.3% |
-16.7% |
-62.3% |
61.9% |
-28.5% |
-34.3% |
-53.6% |
-277.8% |
-14.0% |
Zysk netto (%) |
-28859.3% |
-14675.0% |
-26324.0% |
-162.6% |
-1185.3% |
-1605.6% |
-1198.6% |
-450.0% |
93.1% |
-87.1% |
-90.9% |
-80.6% |
-97.8% |
-116.6% |
-77.7% |
-19.1% |
-23.7% |
-16.7% |
-11.5% |
-4.6% |
8.2% |
6.6% |
EPS |
-11.71 |
-10.71 |
-10.86 |
-6.66 |
-11.04 |
-13.97 |
-15.02 |
-12.61 |
11.22 |
-6.01 |
-5.53 |
-3.4 |
-4.17 |
-6.09 |
-5.07 |
-1.79 |
-2.89 |
-2.08 |
-1.43 |
-0.58 |
1.02 |
0.87 |
EPS (rozwodnione) |
-11.71 |
-10.71 |
-10.86 |
-6.66 |
-11.04 |
-13.97 |
-15.02 |
-12.61 |
11.19 |
-6.01 |
-5.53 |
-3.4 |
-4.17 |
-6.09 |
-5.07 |
-1.79 |
-2.89 |
-2.08 |
-1.43 |
-0.58 |
1.02 |
0.86 |
Ilośc akcji (mln) |
5 |
5 |
7 |
7 |
8 |
9 |
10 |
10 |
10 |
10 |
10 |
10 |
10 |
10 |
10 |
11 |
11 |
11 |
10 |
12 |
12 |
12 |
Ważona ilośc akcji (mln) |
5 |
5 |
7 |
7 |
8 |
9 |
10 |
10 |
10 |
10 |
10 |
10 |
10 |
10 |
10 |
11 |
11 |
11 |
10 |
12 |
12 |
12 |
Waluta |
CHF |
CHF |
CHF |
CHF |
CHF |
CHF |
CHF |
CHF |
CHF |
CHF |
CHF |
CHF |
CHF |
CHF |
CHF |
CHF |
CHF |
CHF |
CHF |
CHF |
CHF |
CHF |